Brenneman, Douglas E <br/><br/>
Chemokine release is associated with the protective action of PACAP-38 against HIV envelope protein neurotoxicity.  [electronic resource] 

 -  Neuropeptides  Aug 2002 
 - 271-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0143-4179 
<br/><br/><label>Standard No.: </label>10.1016/s0143-4179(02)00045-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Newborn<br/>Astrocytes--drug effects<br/>Cell Survival--drug effects<br/>Chemokine CCL4<br/>Chemokine CCL5--metabolism<br/>Chemokines--metabolism<br/>Dose-Response Relationship, Drug<br/>HIV Envelope Protein gp120--toxicity<br/>Indicators and Reagents<br/>Macrophage Inflammatory Proteins--pharmacology<br/>Neuropeptides--pharmacology<br/>Neuroprotective Agents--pharmacology<br/>Pituitary Adenylate Cyclase-Activating Polypeptide<br/>Rats<br/>Vasoactive Intestinal Peptide--pharmacology